ArticleActa pharmacologica Sinica2024

Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation.

Xiu-Chun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.